全文获取类型
收费全文 | 28110篇 |
免费 | 2432篇 |
国内免费 | 1694篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 431篇 |
妇产科学 | 104篇 |
基础医学 | 3608篇 |
口腔科学 | 82篇 |
临床医学 | 2501篇 |
内科学 | 12584篇 |
皮肤病学 | 125篇 |
神经病学 | 94篇 |
特种医学 | 501篇 |
外国民族医学 | 4篇 |
外科学 | 1005篇 |
综合类 | 5370篇 |
现状与发展 | 11篇 |
预防医学 | 2058篇 |
眼科学 | 14篇 |
药学 | 2063篇 |
9篇 | |
中国医学 | 1185篇 |
肿瘤学 | 476篇 |
出版年
2024年 | 32篇 |
2023年 | 349篇 |
2022年 | 607篇 |
2021年 | 766篇 |
2020年 | 820篇 |
2019年 | 952篇 |
2018年 | 851篇 |
2017年 | 935篇 |
2016年 | 1121篇 |
2015年 | 1142篇 |
2014年 | 1773篇 |
2013年 | 1861篇 |
2012年 | 1671篇 |
2011年 | 1984篇 |
2010年 | 1473篇 |
2009年 | 1349篇 |
2008年 | 1379篇 |
2007年 | 1503篇 |
2006年 | 1474篇 |
2005年 | 1199篇 |
2004年 | 1040篇 |
2003年 | 929篇 |
2002年 | 852篇 |
2001年 | 862篇 |
2000年 | 712篇 |
1999年 | 554篇 |
1998年 | 497篇 |
1997年 | 466篇 |
1996年 | 430篇 |
1995年 | 415篇 |
1994年 | 356篇 |
1993年 | 302篇 |
1992年 | 269篇 |
1991年 | 196篇 |
1990年 | 160篇 |
1989年 | 131篇 |
1988年 | 138篇 |
1987年 | 114篇 |
1986年 | 89篇 |
1985年 | 95篇 |
1984年 | 79篇 |
1983年 | 50篇 |
1982年 | 55篇 |
1981年 | 46篇 |
1980年 | 48篇 |
1979年 | 29篇 |
1978年 | 35篇 |
1977年 | 21篇 |
1974年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Propagation of hepatitis A virus in human embryo fibroblasts 总被引:8,自引:0,他引:8
Verena Gauss-Müller Gert G. Frisner Friedrich Deinhardt 《Journal of medical virology》1981,7(3):233-239
human diploid fibroblasts and human primary liver cell carcinoma cells (PLC/PRF/5) were infected with hepatitis A virus (HAV) adapted to growth in cell culture or derived directly from human stool. Viral antigen was expressed in PLC/PRF/5 cells 28 days after infection with cell culture-adapted HAV, and 50 days after infection with virus from human stool. In human fibroblasts the periods until first expression of viral antigen were 90 and 210 days, respectively. During further passages of HAV in fibroblasts the time of first appearance of antigen decreased to about 28 days. Biophysical properties of HAV extracted from infected fibroblasts were comparable to those of HAV derived directly from human stool. Immunofluorescence studies showed that the antigen was located exclusively within the cytoplasm of the infected fibroblasts. Kinetics of antigen production indicated that an equilibrium between virus multiplication and cell metabolism was reached in persistently infected fibroblasts. 相似文献
92.
Comparison of the COBAS TaqMan HBV test with the COBAS Amplicor monitor test for measurement of hepatitis B virus DNA in serum 总被引:3,自引:0,他引:3
Quantitation of low hepatitis B virus (HBV) DNA levels in patients with chronic hepatitis B is important for monitoring natural history of disease and treatment efficacy. This study aimed to compare the quantitation range and analytical sensitivity of the newly developed COBAS TaqMan HBV test (TaqMan test) with the COBAS Amplicor HBV Monitor Test (Amplicor test), using the Eurohep HBV reference plasma and serum samples from patients. Serial dilutions (2.7x10(1)-2.7x10(8) copies/ml) of the Eurohep HBV reference plasma and 50 serum samples from chronic hepatitis B patients were tested by both assays. The TaqMan test could detect seven (2.7x10(2)-2.7x10(8) copies/ml) of eight dilutions of the reference plasma, while the Amplicor test could only detect three of them (2.7x10(3)-2.7x10(5) copies/ml). The HBV DNA values measured by the TaqMan test correlated very well with the theoretical Eurohep standard values (r=0.998, P<0.001). There were good correlations between the HBV DNA levels measured by the two assays on both the Eurohep reference plasma (r=0.993, P<0.001) and serum samples from patients (r=0.904, P<0.001). Compared to the Amplicor test, the TaqMan test had a higher sensitivity (50 vs. 300 copies/ml), shorter assay time (6 vs. 10 hr), and wider dynamic range (8 vs. 3 logs), and was more cost-effective in a clinical setting. These data indicate that the TaqMan test is an excellent tool for HBV DNA quantitation. 相似文献
93.
94.
Sadataka Inuzuka Takato Ueno Hideo Tateishi Takuji Torimura Michio Sata Kyuichi Tanikawa Masamichi Kojiro 《Pathology international》1994,44(5):391-397
Elevation of the serum angiotensin-converting enzyme (sACE) level and hepatic granulomas were found during a clinical relapse in a 22 year old patient with acute viral hepatitis type A (AVH-A). The serum transaminase level and sACE level remained high for more than 6 months. In the biopsied specimen of the liver, fibrous rings of granulomas composed of collagen types I, III, and V were observed. Furthermore, the localization of ACE was visible in the rough endoplasmic reticulum of epithelioid cells of granulomas in the liver under electron microscopy using the indirect immunoperoxidase method. These results suggest that granuloma cells in the liver caused by hepatitis A may be involved in ACE production. In addition, other diseases associated with the presence of granulomas in the liver, such as lymphoma, cytomegalovirus infection, visceral leishmaniasis, and lupoid hepatitis, were ruled out. However, the hepatic granulomas disappeared with the healing of AVH-A. In this regard, the present case is considered to be one of the very few cases of hepatic sarcoidosis. 相似文献
95.
Dissociation of hepatitis A virus antigen-anti-HAV antibody complexes by 2-mercaptoethanol and dithiothreitol 总被引:1,自引:0,他引:1
D W Bradley K A McCaustland E H Cook H A Fields G G Frosner J E Maynard 《Journal of medical virology》1982,9(4):311-325
Intravenous inoculation of two marmosets and one chimpanzee with hepatitis A virus (HAV) resulted in the replication of virus in liver, excretion of HAV particles in stool, and the appearance of circulating antibodies specific for hepatitis A. The development of an early antibody response in the chimpanzee and in one of the two infected marmosets was shown to interfere with the serologic detection of HAV antigen (HAV Ag) in homogenates of acute phase liver tissue obtained from these animals. Treatment of HAV Ag-positive and IgM anti-HAV-positive liver homogenates with thiol reducing compounds was shown to release HAV Ag from in vitro formed immune complexes. The increased RIA response for HAV Ag in homogenates treated with 2-mercaptoethanol (2-ME) or dithiothreitol (DTT) was further shown not to be due to activation of HAV Ag itself or to a nonspecific effect on the RIA coating antibody, radiolabeled probe, or homogenized liver tissue. IgG and IgM double-antibody sandwich RIAs for HAV Ag were also compared for their ability to detect HAV Ag under reducing and nonreducing conditions. Application of the 2-ME or DTT treatment procedure to the serologic detection of other viral antigens or viruses whose presence in blood, stool, tissue macerate, or other milieu may be masked by specific antibody appears to be feasible. 相似文献
96.
Prof. Dr. C. -P. Sodomann G. Maerker-Alzer K. Havemann C. Dienst H. Schultz D. Mitrenga K. Schumacher G. A. Martini 《Journal of molecular medicine (Berlin, Germany)》1979,57(17):893-903
Summary It is a clinically and experimentally well supported working hypothesis that infection with hepatitis B virus may result in chronic active hepatitis in patients with suspected immune deficiencies. On this basis, a pilot study was performed in order to evaluate the effect of specific transfer factor (TF) in the treatment of HBs-Ag-positive chronic active hepatitis. From the leukocytes of 500 ml venous blood each of 40 volunteers that had completely recovered from acute virus hepatitis B within the last 6 months, a unique TF pool (40 units of TF) was prepared according to the method of Lawrence. Preexaminations indicated that this preparation was able to enhance cellular immune reactions in vitro. Thirteen patients with HBs-antigenemia and chronic active hepatitis (i.e., two liver biopsies within the last 6 or more months with the histological criteria of chronic aggressive hepatitis according to de Groote, elevated serum levels of bilirubin, alkaline phosphatase, transaminase activities, and/or -globulines) were randomized: Seven received s.c. injections of two units of TF each on days 1 and 15, the other six saline. Conversion of skin reactions to some ubiquitous antigens occurred in the TF group, but no significant and constant drop of HBs-Ag serum titers was observed. Although some of the biochemical parameters seemed to ameliorate in the TF group, the differences versus the control group did not prove to be significant within the limited number of patients under observation. The in vitro reactivity of patients' lymphocytes to HBs-Ag, tested by means of the3H-thymidine uptake, was never found enhanced after TF application. In the used doses, specific TF was not effective in the treatment of HBs-Ag-positive chronic active hepatitis; unfavorable side-effects were not observed. 相似文献
97.
Wolf Szmuness Cladd E. Stevens Edward J. Harley Edith A. Zang Patricia E. Taylor Harvey J. Alter The Dialysis Vaccine Trial Group 《Journal of medical virology》1981,8(2):123-129
Three hundred thirty-six medical personnel from hemodialysis centers were treated with three doses, 20 μg each, of the Merck hepatitis B vaccine (at 0, 1, and 6 months). Within 1 month after the first injection, 41% converted to anti-HBs positivity; after the second injection the conversion rate rose to 80–90%; and after the booster, to 96–98%. The later rate remained unchanged during the 18-month follow-up period. Only 2.8% of those vaccinated did not respond to the vaccine. The patterns of immune responses to 20-μg doses were found to be exactly the same as to 40-μg doses. It is suggested that reduced doses of vaccine should be as efficacious as the larger ones. 相似文献
98.
Manabu Daikoku Keisuke Nakata Keisuke Hamasaki Akio Ido Kazuhiko Nakao Yuji Kato Michiaki Koga Michitami Yano Shigenobu Nagataki 《Journal of medical virology》1995,47(2):184-188
Hepatitis B virus (HBV), with a G-to-A point mutation at nucleotide 83 in the precore region (mutant HBV83), accounts for most cases of hepatitis B e antigen (HBeAg)-defective HBV. However, it is still not clear how mutant HBV83 is associated with HBe seroconversion. Twenty-six HBeAgpositive patients with chronic hepatitis B who received oral prednisolone (30 mg/day) for 3 weeks were studied to clarify the prevalence of mutant HBV83 during the treatment using polymerase chain reaction with a restriction fragment length polymorphism assay. Twelve (46%) patients seroconverted to anti-HBe 1 year after treatment, whereas 14 (54%) did not. The proportion of mutant HBV83 to whole HBV remained unchanged in both groups during an acute exacerbation induced by withdrawal of corticosteroids. Among 12 anti-HBe-0seroconverted patients, five (56%) of nine patients with only wild-type HBV at baseline developed detectable levels of mutant HBV83 while all three patients with a mixed viral population of wild-type HBV and mu tant HBV83 at baseline developed a higher pro portion of mutant HBV83 one year after treat ment. In contrast, these changes were observed in only one (14%) of seven who failed to seroconvert. The results indicate that a flare-up of hepa titis precedes emergence or selection of mutant HBV83, followed by HBe seroconversion in patients with chronic hepatitis B. © 1995 WiIey-Liss, Inc. 相似文献
99.
Seventy five patients with acute and chronic active hepatitis (CAH) were studied by indirect immunofluorescence with monoclonal antibodies for the presence of hepatitis B surface antigen (HBsAg) on peripheral blood mononuclear cells (PBMC). The viral surface antigen was detected in the PBMC of all the patients with hepatitis B virus (HBV)-induced CAH and in acute patients with more than 2 months of evolution. No HBsAg was detected in the samples obtained from 12 normal controls or from 14 non-A, non-B CAH patients. Analysis of PBMC subsets revealed that HBsAg was present in non-T cells; dual fluorescence studies showed HBsAg on surface Ig-positive lymphocytes. The binding of anti-HBs monoclonal antibodies was higher than that of a goat anti-HBs serum, and the highest reactivity was observed with an antibody against the pre-S(2)-region sequence. Both HBsAg and hepatitis B core antigen (HBcAg) were also detected in lysates of PBMC by dot blot analysis. 相似文献
100.
重型病毒性肝炎中丁型肝炎病毒的检测 总被引:1,自引:0,他引:1
为了探讨丁型肝炎病毒(HDV)感染在重型病毒性肝炎中的作用,对北京佑安医院1980年至1989年收治的54例急性和亚急性重型肝炎和38例急性乙肝患者血清,应用国产HDVELISA试剂测定抗-HD、抗-HDIgM和HDAg,应用斑点杂交技术测定HDVRNA。结果发现重型肝炎组HOV-M检出率明显高于急性乙肝组(27.8%比5.3%.P<0.05)。单独HBV感染和HDV/HBV混合感染的重型肝炎患者均有较高的病死率。提示HDV感染是重型肝炎中重要的病原学因素之一,HDV与HBV具有协同作用加重肝损害,导致肝衰竭。 相似文献